Symbols

LENZ

LENZ Therapeutics·NASDAQ

--(--)

LENZ fundamentals

LENZ Q4 2025 Earnings

LENZ Therapeutics (LENZ) released its earnings on Mar 24, 2026: revenue was 1.59M (YoY --), missed estimates; EPS was -1.16 (YoY -152.17%), missed estimates.

Revenue / YoY

1.59M

EPS / YoY

-1.16

-152.17%

Report date

Mar 24, 2026

LENZ Earnings Call Summary for Q4,2025

**Category leadership solidified with 10,000+ ECPs and 45,000 boxes sold in Q1 2026.
DTC campaign drives 5x website traffic growth.
2027 global expansion pipeline with 10+ potential approvals.

Earnings

EPS

Revenue

Revenue & Expenses

LENZ has released its 2025 Q4 earnings report, with revenue of 1.59M, reflecting a YoY change of NaN%, and net profit of -35.90M, showing a YoY change of -183.72%. The Sankey diagram below clearly presents LENZ's revenue sources and cost distribution.

Key Indicators

LENZ Therapeutics (LENZ) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

LENZ Therapeutics (LENZ)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

LENZ Therapeutics (LENZ)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

LENZ Therapeutics (LENZ)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown